Outset Medical (NASDAQ:OM) Given Sector Perform Rating at Royal Bank of Canada

Outset Medical (NASDAQ:OM)‘s stock had its “sector perform” rating reissued by equities research analysts at Royal Bank of Canada in a research note issued on Tuesday,Benzinga reports. They currently have a $3.00 price target on the stock. Royal Bank of Canada’s price objective points to a potential upside of 206.12% from the stock’s previous close.

Outset Medical Trading Down 10.9 %

OM opened at $0.98 on Tuesday. The stock has a market cap of $51.49 million, a PE ratio of -0.36 and a beta of 2.05. The company has a quick ratio of 5.04, a current ratio of 6.49 and a debt-to-equity ratio of 4.12. Outset Medical has a twelve month low of $0.44 and a twelve month high of $5.27. The company has a fifty day moving average of $0.99 and a 200-day moving average of $1.50.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently made changes to their positions in the business. GSA Capital Partners LLP raised its holdings in shares of Outset Medical by 924.7% during the third quarter. GSA Capital Partners LLP now owns 1,111,612 shares of the company’s stock valued at $753,000 after purchasing an additional 1,003,135 shares during the period. Massachusetts Financial Services Co. MA raised its stake in Outset Medical by 118.5% during the 2nd quarter. Massachusetts Financial Services Co. MA now owns 1,538,859 shares of the company’s stock worth $5,925,000 after buying an additional 834,663 shares during the period. Millennium Management LLC boosted its holdings in Outset Medical by 58.8% in the second quarter. Millennium Management LLC now owns 1,942,899 shares of the company’s stock worth $7,480,000 after acquiring an additional 719,412 shares in the last quarter. Marshall Wace LLP boosted its holdings in Outset Medical by 487.8% in the second quarter. Marshall Wace LLP now owns 314,187 shares of the company’s stock worth $1,210,000 after acquiring an additional 260,740 shares in the last quarter. Finally, Point72 Asset Management L.P. bought a new stake in shares of Outset Medical during the second quarter valued at approximately $827,000.

Outset Medical Company Profile

Outset Medical, Inc, a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables.